Methotrexate induced pancytopenia is rare and concern for it should not limit its use.

作者信息

Yazici Y

出版信息

Rheumatology (Oxford). 2006 Mar;45(3):361; author reply 363-4. doi: 10.1093/rheumatology/kei199. Epub 2005 Dec 6.

DOI:10.1093/rheumatology/kei199

PMID:16332954

Abstract

摘要

相似文献

Methotrexate induced pancytopenia is rare and concern for it should not limit its use.

Rheumatology (Oxford). 2006 Mar;45(3):361; author reply 363-4. doi: 10.1093/rheumatology/kei199. Epub 2005 Dec 6.

Methotrexate induced neutropenia associated with coprescription of penicillins: serious and under-reported?

Rheumatology (Oxford). 2006 Mar;45(3):361-2; author reply 363-4. doi: 10.1093/rheumatology/kei200. Epub 2005 Dec 6.

[Serious adverse effects of methotrexate therapy in patients with rheumatic arthritis].

Duodecim. 1998;114(21):2187-90.

[A case of pneumocystis carinii pneumonia associated with low dose methotrexate treatment for rheumatoid arthritis and trimethoprim-sulphamethoxazole induced pancytopenia].

Arerugi. 2004 Jun;53(6):575-81.

Pancytopenia and severe cytopenia induced by low-dose methotrexate. Eight case-reports and a review of one hundred cases from the literature (with twenty-four deaths).

Rev Rhum Engl Ed. 1995 Jul-Sep;62(7-8):477-86.

Comment: severe pancytopenia associated with methotrexate therapy for rheumatoid arthritis.

Ann Pharmacother. 2002 Jul-Aug;36(7-8):1295. doi: 10.1345/aph.19113b.

Serious pancytopenia from methotrexate treatment of psoriatic arthritis.

Am J Emerg Med. 2006 May;24(3):392-4. doi: 10.1016/j.ajem.2005.11.022.

Pancytopenia associated with leflunomide and methotrexate.

Ann Pharmacother. 2003 Jan;37(1):149. doi: 10.1345/aph.1C293.

Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years.

Rheumatology (Oxford). 2005 Aug;44(8):1051-5. doi: 10.1093/rheumatology/keh685. Epub 2005 May 18.

Fatal Cytopenia Induced by Low-Dose Methotrexate in Elderly With Rheumatoid Arthritis. Identification of Risk Factors.

Am J Ther. 2017 Jan/Feb;24(1):e106-e107. doi: 10.1097/MJT.0000000000000486.

引用本文的文献

Factors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases.

PLoS One. 2016 Apr 29;11(4):e0154744. doi: 10.1371/journal.pone.0154744. eCollection 2016.

Pott's disease and hypercalcemia in a patient with rheumatoid arthritis receiving methotrexate monotherapy.

Indian J Pharmacol. 2013 Nov-Dec;45(6):631-3. doi: 10.4103/0253-7613.121385.

Metabolism and disposition of a novel antineoplastic JS-38 (Benzamide, N-[4-(2,4-dimethoxyphenyl)-4,5-dihydro-5-oxo-1,2-dithiolo[4,3-b]pyrrol-6-yl]-3,5-bis (trifluoromethyl)-(9Cl)) in rats.

Eur J Drug Metab Pharmacokinet. 2012 Mar;37(1):45-56. doi: 10.1007/s13318-011-0055-8. Epub 2011 Jul 30.

The pharmacokinetics of JS-38, a novel antineoplastic drug, in rats.

Eur J Drug Metab Pharmacokinet. 2008 Jul-Sep;33(3):143-8. doi: 10.1007/BF03191111.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验